CRIS Current Research Information System

TARTAGNI, ELISA

TARTAGNI, ELISA  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.013 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
2B02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE: DATA FROM THE BRISIGHELLA HEART STUDY Cicero, A; Rosticci, M; Tartagni, E; Parini, A; Grandi, E; D'Addato, S; Borghi, C; Group, Bhs 2015-01-01 JOURNAL OF HYPERTENSION - 1.06 Abstract in rivista -
Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. Cicero A.F.G.; Tartagni E 2012-01-01 HOSPITAL PRACTICE - 1.01 Articolo in rivista -
Diet, dietary supplements and age-related macular degeneration (AMD) Cicero AFG.; Tartagni E. 2014-01-01 NUTRAFOODS - 1.01 Articolo in rivista -
Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study. Cicero AF; Reggi A; Tartagni E; Grandi E; D'Addato S; Borghi C; Brisighella Heart Study 2013-01-01 ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE - 1.01 Articolo in rivista -
Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence. Cicero AF; Tartagni E; Ertek S. 2014-01-01 EXPERT OPINION ON BIOLOGICAL THERAPY - 1.01 Articolo in rivista -
Nutraceuticals for metabolic syndrome management: from laboratory to benchside. Cicero AF; Tartagni E; Ertek S. 2014-01-01 CURRENT VASCULAR PHARMACOLOGY - 1.01 Articolo in rivista -
Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction? Cicero AFG; Tartagni E; Borghi C. 2012-01-01 CLINICAL LIPIDOLOGY - 1.01 Articolo in rivista -
Proposal of a non-invasive approach for biomechanical follow-up of heart failure patients. I. Corazza; E. Tartagni; F. Marangoni; R. Zannoli 2008-01-01 - s.n 4.02 Riassunto (Abstract) -
Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data Cicero AF; Tartagni E; Ertek S. 2014-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -